Announcement of Lukang Pharmaceutical on the results of independent exercise of the 2019 Stock Options Incentive Plan for the fourth quarter of 2023 and stock changes

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.